| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |